Skip to main content
. 2023 Nov 2;14:1221158. doi: 10.3389/fpsyt.2023.1221158

Table 3.

Scores on the psychometric scales at baseline and 6-month endpoint of the entire sample (N = 60) and of the sample subdivided according to psychotherapy received [MIT (n = 18) vs. TAU (n = 39)].

Scales SE Effect size# 95% CI p
Entire sample
GAF BL 6.22 0.119 −1.273 From −1.611 to −0.929 <0.001
GAF 6-mo. 7.40 0.153
BPRS BL 51.65 1.892 1.633 From 1.242 to 2.017 <0.001
BPRS 6-mo. 33.55 1.087
CGI-S BL 3.85 0.134 0.928 From 0.622 to 1.229 <0.001
CGI-S 6 mo. 2.33 0.152
MIT vs. TAU
GAF BL MIT 6.11 0.179 0.210 From −0.352 to 0.769 0.464
GAF BL TAU 6.31 0.161
BPRS BL MIT 54.17 2.324 −0.331 From −0.892 to 0.234 0.250
BPRS BL TAU 49.41 2.557
CGI-S BL MIT 3.61 0.216 0.323 From −0.242 to 0.884 0.262
CGI-S BL TAU 3.95 0.176
GAF 6 mo. MIT 7.72 0.253 −0.394 From −0.956 to 0.174 0.173
GAF 6 mo. TAU 7.26 0.197
BPRS 6 mo. MIT 29.56 0.833 0.659 From 0.077 to 1.232 0.025
BPRS 6 mo. TAU 34.82 1.493
CGI-S 6 mo. MIT 1.94 0.206 0.390 From −0.178 to 0.953 0.177
CGI-S 6 mo. TAU 2.56 0.204

#Cohen’s d, approximately 0.2 = small, approximately 0.5 = medium, approximately 0.8, or more = large.

BL, baseline; BPRS, Brief Psychiatric Rating Scale total scores; CGI-I, Clinical Global Impressions – Improvement scale; CGI-S, Clinical Global Impressions – Severity scale; GAF, Global Assessment of Functioning; MIT, metacognitive interpersonal therapy; N, number of cases; SE, standard error; TAU, treatment-as-usual; x̄, mean; 6 mo., 6-month endpoint; 95% CI, 95 percent confidence intervals.